First Episode Psychosis and Pathway to Care in Nordland

First episode psychosis patients often experiences treatment delay. This reduces their prospects for recovery and makes unnecessary burdens for them and their carers. A better understanding of help seeking intentions is required, and has not been explored in a county like Nordland, Norway, with long distances and challenging access to health services. The purpose of this study is to explore the process of help seeking, including how patients and their careers discover and understand the psychotic symptoms. Research exploring the impact on families mainly focuses on parents' experiences, and there are less studies focusing on experiences and needs of siblings. This study will therefore explore siblings' experiences separate from their parents. Methods will be qualitative interviews with patients, their carers and siblings. Analysis will be influenced by Grounded theory.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

First Episode Psychosis

Age range

16 year–35 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 16-35,
understand and speak Norwegian
able to give consent
no learning disabilities

Exclusion criteria

Treatment and study plan

Primary outcomes

Patient experience

Time frame: up to 100 weeks
Carers experiences

Time frame: up to 100 weeks
Siblings experiences

Time frame: up to 100 weeks
Pathway to care

Time frame: up to 100 weeks

Sponsors and collaborators

Lead sponsor

Nordlandssykehuset HF

Other

Registry information

Official study title

Patients and Carers Experiences With First Episode Psychosis and Pathway to Care in Nordland: A Qualitative Study

Important dates

Study start: 2013
Primary completion: 2018
Study completion: 2018
First posted: Dec 20, 2012
Registry last updated: May 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed